Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Pharmaceuticals (Basel, Switzerland)|December 18, 2020
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance ProjectGiorgia Teresa Maniscalco, Vincenzo Brescia Morra, Ciro Florio, et al.
Journal of Neurology|July 10, 2026
Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 studyMassimo Filippi, Luigi M E Grimaldi, Vincenzo Brescia Morra, et al.
Multiple Sclerosis and Related Disorders|February 25, 2026
Real-world evaluation of the transition between originator and follow-on glatiramer acetate in people with multiple sclerosis: the "GA transition" studyIrene Schiavetti, Pietro Annovazzi, Cinzia Cordioli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 17, 2021
[Acute severe respiratory distress in chronic haemodialytic patients affected by SARS-CoV-2 pneumonia: prevalence and associated factors. A single-centre experience from Cardarelli Hospital in Naples (Italy)]Valerio Bertino, Olga Credendino, Livia Sorrentino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 18, 2021
Disability assessment using Google MapsLuigi Lavorgna, Pietro Iaffaldano, Gianmarco Abbadessa, et al.
Journal of Neurology|August 27, 2024
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)Clara Grazia Chisari, Maria Pia Amato, Alessia Di Sapio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapyElisabetta Signoriello, Giacomo Lus, Simona Bonavita, et al.
Plos One|June 28, 2016
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective StudyEmanuele D'Amico, Carmela Leone, Giusi Graziano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 5, 2022
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational studyDamiano Baroncini, Angelo Ghezzi, Clara Guaschino, et al.
Neurology and Therapy|June 2, 2022
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up StudyMaria Petracca, Serena Ruggieri, Elena Barbuti, et al.
Pageof 12